| Severe acute respiratory syndrome (SARS) |
|
|---|---|
| Other names | Sudden acute respiratory syndrome[1] |
 |
|
| Electron micrograph of SARS coronavirus virion | |
| Pronunciation | |
| Specialty | Infectious disease |
| Symptoms | Fever, persistent dry cough, headache, muscle pains, difficulty breathing |
| Complications | Acute respiratory distress syndrome (ARDS) with other comorbidities that eventually leads to death |
| Usual onset | 4–6 days post-exposure |
| Causes | Severe acute respiratory syndrome coronavirus (SARS-CoV-1) |
| Prevention | N95 or FFP2 respirators, ventilation, UVGI, avoiding travel to affected areas[2] |
| Prognosis | 9.5% chance of death (all countries) |
| Frequency | 8,096 total confirmed cases (2002–2004), no new cases since 2004 |
| Deaths | 783 known |
| Severe acute respiratory syndrome (SARS) |
|
|---|---|
| Other names | Sudden acute respiratory syndrome[1] |
|
|
| Electron micrograph of SARS coronavirus virion | |
| Pronunciation | |
| Specialty | Infectious disease |
| Symptoms | Fever, persistent dry cough, headache, muscle pains, difficulty breathing |
| Complications | Acute respiratory distress syndrome (ARDS) with other comorbidities that eventually leads to death |
| Usual onset | 4–6 days post-exposure |
| Causes | Severe acute respiratory syndrome coronavirus (SARS-CoV-1) |
| Prevention | N95 or FFP2 respirators, ventilation, UVGI, avoiding travel to affected areas[2] |
| Prognosis | 9.5% chance of death (all countries) |
| Frequency | 8,096 total confirmed cases (2002–2004), no new cases since 2004 |
| Deaths | 783 known |
